<DOC>
	<DOC>NCT03104088</DOC>
	<brief_summary>Comparing the cognitive levels of patients with SPG4 mutations to healthy controls.</brief_summary>
	<brief_title>Studying Cognition in SPG4</brief_title>
	<detailed_description>Comparing the cognitive levels of patients with SPG4 mutations to healthy controls by using the CANTABÂ® and MoCA.</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Paraplegia</mesh_term>
	<mesh_term>Spastic Paraplegia, Hereditary</mesh_term>
	<criteria>Patient with SPG4 with known SPASTMutation (patient group) or healthy control Age 18 to 70 years Written, informed consent Lack of ability for a written, informed consent Presence of gait disorder or other neurological condition (for healthy controls)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>